Psoriasis

Largest Survey of Its Kind Finds That People With Psoriasis Are at Risk for Other Medical Conditions

National Psoriasis Foundation data show more than half of those with psoriasis have other health issues PORTLAND, Ore., Aug. 6 /PRNewswire-USNewswire/ -- Emerging research reveals that people with psoriasis are at risk for developing other serious medical conditions in...

New Source of Information on Psoriasis Medications

NeedyMeds.org and the National Psoriasis Foundation announce a new source of information on psoriasis medications and the financial help available for those living with the disease (Vocus) June 29, 2009 -- NeedyMeds, a national nonprofit, added a new resource page to ...

American Academy of Dermatology Issues New Guidelines For the Management of Psoriasis With Systemic Medications

Dermatologists emphasize treatment should be tailored to meet individual patients' needs SCHAUMBURG, Ill., June 4 /PRNewswire-USNewswire/ -- Based on an extensive review of scientific literature on psoriasis and the opinion of recognized psoriasis experts, the American Academy of Dermatol...

Having Psoriasis Raises Risk of Diabetes, Hypertension

Researchers suspect chronic inflammation is common thread among all 3 conditions MONDAY, April 20 (HealthDay News) -- A new study lends more credence to a long-suspected connection between psoriasis, diabetes and hypertension. Researchers reporting in the April issue of the Archive...

BioTrends Prepares to Field ChartTrends(TM) Reports to Cover the Use of Biologic Agents in Psoriasis and Rheumatoid Arthritis

EXTON, Pa., March 16 /PRNewswire/ -- BioTrends Research Group, Inc. has been covering the biologics market for Psoriasis and RA through its TreatmentTrends(TM) series which are syndicated primary research reports based on self reported survey data collected from Dermatologists and Rheumatologi...

LeAnn Rimes Shares Her Personal Struggle With Psoriasis in Nation's Capital

Grammy Award-winning singer advocates for research into disease afflicting 7.5 million Americans WASHINGTON, March 11 /PRNewswire-USNewswire/ -- Grammy Award-winning artist LeAnn Rimes shared her personal story on Capitol Hill today about growing up with psoriasis, and she encouraged lawmaker...

American Academy of Dermatology Issues New Guidelines For The Management of Psoriasis With Topical Therapies

Dermatologists cite high efficacy-to-safety ratio of topical agents for patients with mild to moderate psoriasis SCHAUMBURG, Ill., March 2 /PRNewswire-USNewswire/ -- The American Academy of Dermatology (Academy) has released new guidelines of care for the management and treatment of psoriasis...

FDA Warns Users on Psoriasis Drug

Three have died from rare brain infection while taking Raptiva, officials report in health advisory THURSDAY, Feb. 19 (HealthDay News) -- U.S. health officials issued a public health advisory Thursday for the psoriasis drug Raptiva after confirming that three people using the medicatio...

Gene Insights May Improve Psoriasis Care

Scientists have spotted DNA potentially linked to the disease TUESDAY, Jan. 27 (HealthDay News) -- U.S. researchers say they've spotted genetic "hot spots" associated with psoriasis, a finding that could lead to new drug targets and tailored treatments for the autoimmune skin disease. ...

An Oral Agent for the Treatment of Moderate to Severe Psoriasis Would Earn a Higher Patient Share in the United States than in Europe

Stelara Will Earn Decision Resources' Clinical Gold-Standard for Psoriasis in 2012, According to a New Report from Decision Resources WALTHAM, Mass., Jan. 21 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, fi...

More>>

Psoriasis in Medical Technology

Innovative Psoriasis Treatment PSORENT(R) Announces Healthcare Cost Savings Potential Consistent with President Obama's Announcement on Healthcare Reform

PRINCETON, N.J., June 25 /PRNewswire/ -- "Congratulations President Obama on your agreement with large pharmaceutical companies to cut prescription costs for the elderly," says Mark D. Steele, president of NeoStrata Company, Inc. "We thought you should know that you have a little company in New Je...

Dermatologists Caution That Severe Cases of Psoriasis Can Be Associated With Other Serious Medical Conditions

SAN FRANCISCO, March 5 /PRNewswire-USNewswire/ -- On the surface, the thick, red, scaly, itchy plaques of psoriasis -- which have been shown to have a significant negative impact on a person's overall quality of life -- may not appear to pose a serious health risk for patients. However, a growing ...

CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients

MAIDENHEAD, England, November 21 /PRNewswire-FirstCall/ -- - Not for UK Journalists The European Committee for Medicinal Products for Human Use (CHMP) today announced its positive recommendation for the approval of Enbrel(R) (etanercept) as a treatment for children aged 8 years and...

Continuous Treatment With Abbott's HUMIRA(R) Achieves Superior Long-Term Efficacy for Psoriasis Patients Compared to Interrupting Treatment

Additional Analysis Shows HUMIRA Effectively Treats Adult Patients with Moderate to Severe Psoriasis Regardless of Age, Duration of Disease, Diagnosis of Psoriatic Arthritis or Recent Systemic Therapy PARIS, Sept. 18 /PRNewswire-FirstCall/ -- More psoriasis patients achieve efficacy when...

Anacor Pharmaceuticals Announces Positive Results from Phase 2a Clinical Trial of AN2728 in Psoriasis Patients

PALO ALTO, Calif., March 25 /PRNewswire/ -- Anacor Pharmaceuticals today announced results from a Phase 2a clinical trial of AN2728, an investigational topical anti-inflammatory drug, in patients with psoriasis. The study met its primary endpoint and all secondary endpoints. In 69 percent of...

REMICADE-Treated Patients Experienced Rapid and Substantial Improvement in Psoriasis in Critical Regions of Body

Marked Improvement in Four Regions of Body Consistent with Overall PASI Response in REMICADE-Treated Patients SAN ANTONIO, Feb. 4 /PRNewswire/ -- Data from an integrated analysis of three randomized, placebo-controlled trials showed patients with moderate to severe plaque psori...

Rigel Announces Initiation of Phase 1 Clinical Trial of R348 for Rheumatoid Arthritis, Psoriasis and Other Immune Disorders

SOUTH SAN FRANCISCO, Calif., Jan. 9 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) announced today that it has begun enrolling patients in a Phase 1 study to evaluate the safety and tolerability of R348, an orally available, potent inhibitor of Janus Kinase 3 (JAK3), as...

Study Linking Increased Risk of Death to Severe Psoriasis a Call to Action

National Psoriasis Foundation urges psoriasis patients to take control of their health, help work for a cure PORTLAND, Ore., Dec. 19 /PRNewswire-USNewswire/ -- A study released this week showing that people with severe psoriasis are likely to have a shorter life expectancy should prompt th...

Abbott's ABT-874 Shows Positive Results for Maintenance of Response in Phase II Psoriasis Study

Study Data Show Patients with Moderate to Severe Psoriasis Who Responded to Anti-IL-12/23 ABT-874 after 12 Weeks of Treatment, Maintained Response at 24 Weeks BUENOS AIRES, Argentina, Oct. 1 /PRNewswire-FirstCall/ -- Results from an extension to a Phase II study e...

Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis

- Interim Findings To Be Presented in a Poster Session at the 67th Annual Meeting of the American Academy of Dermatology - SAN FRANCISCO, March 6 /PRNewswire/ -- Galderma Laboratories, L.P. today announced interim findings from a study of sequential treatment of plaque psoriasis using Clobex ...

Psoriasis in Medical Products

Excilite

Description:... Excilite is a new and powerful instrument for the dermatologist, a monochromatic excimer light system (MEL @308 nm - UVB) for rapid treatment of psoriasis and vitiligo. Designed to treat recalcitrant plaques, it allows for homogeneous and targeted exposure of extensive lesions without irradiating the res...
Company:DEKA Research & Development Corp.

Psoriasis in Medical Definition

Photomedicine

... 3 External links 3.1 Journals and Societies 3.2 Miscellaneous Examples PUVA for the treatment of psoriasis Photodynamic therapy (PDT) for treatment of cancer and macular degeneration Free electron laser Laser hair removal Optical diagnostics,...

Psoriasis in Medical Dictionary

Psoriasis

Psoriasis is a chronic, non-contagious autoimmune disease which affects the skin and joints. It commonly causes red scaly patches to appear on the skin. The scaly patches caused by psoriasis , called psoriatic plaques, are... Read about psoriasis symptoms, causes, treatment infor...

Scaly skin

...related topics at LIVESTRONG.COM, the definitive daily health, fitness, and lifestyle destination. Scaly skin , Scaly skin diseases course. psoriasis overview. Authoritative facts about the skin from the New Zealand Dermatological Society. Authoritative facts about the skin from the New Zeal...

Pustules

...... pustule . Pustules . pustulosis. pustulosis palmaris et plantaris. put down. put ... Information on pustular psoriasis, an uncommon form of psoriasis characterized by clearly defined, raised bumps on the skin that are filled with pus ( pustules ) Washing your face won't clear your skin of...

Psoriatic arthritis

...tis :427-436 :194 that, according to the National psoriasis Foundation, affects around 10-30% of people suffer...s a specific condition in which a person has both psoriasis ... People with psoriatic arthritis might not...ve or ... Reviewed by leaders in the field of psoriasis research, this article provides an overview of p...

Lentigines

...of multiple lentigines . Multiple lentigines on neck and trunk (may ... Development of lentigines in zones previously affected by plaques of psoriasis ... The lentigines were not present before the treatment although the patients have ... People with this condition have large numbers of len...

Coal tar

...tions, ... Coal Tar products have been used for the treatment of psoriasis ... steroids, there was coal tar . ... Coal tar preparations appear to exert their anti ... ... Epidemiology Studies of psoriasis Patients Who. Received Coal Tar Therapy. ... 4.1-5 Estimates of Lifetim...

Acrodermatitis

...odermatitis continua of Hallopeau is a rare, chronic, sterile pustular ... Histologically, acrodermatitis continua displays features of pustular psoriasis ... acrodermatitis enteropathica ( ′akrō′dərmə¦tītəs ′entərə′pathəkə ) ( medicine ) An often fatal inherited disease involving inefficient ...

Psoriasis in Biological News

Missing genes link to psoriasis

Genetics experts at The University of Nottingham have been involved in a scientific breakthrough which is helping to explain why some people may be more likely to suffer from the chronic skin condition, psoriasis. The research, which has just been published in the journal Nature Genetics , sho...

Researchers identify 4 genetic hotspots associated with psoriasis

SALT LAKE CITY A genomewide scan of millions of genetic mutations has revealed four new DNA "hotspots" that affect the risk for psoriasis, a national group of researchers led by the University of Michigan and including several from the University of Utah School of Medicine has shown in a just-pub...

Scientists uncover new genetic variations linked to psoriasis

Two international teams of researchers have made significant gains in understanding the genetic basis of psoriasis, a chronic skin condition that can be debilitating in some patients. Their research, involving thousands of patients, is reported in two studies published this week in the advance onl...

U-M scientists identify major psoriasis susceptibility gene

University of Michigan scientists have found a common genetic variation in an immune system gene that makes people much more likely to develop psoriasis ?a disfiguring inflammatory skin disease. Named PSORS1 (SORE-ESS-1), for psoriasis susceptibility 1, the gene is the first genetic determinant o...

NYU Langone Medical Center awarded NIH grants totaling $1,560,000

..., 2009 Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are t...

Tips from the American Journal of Pathology

...009, 174: 1347-1357 Mouse Model of Human psoriasis Researchers led by Nicole Ward at Case Western...9 issue of The American Journal of Pathology . psoriasis is a chronic inflammatory disease that causes red ...s, and the presence of white blood cells. Study of psoriasis has been limited, however, due to the absence of a...

Small molecules block cancer gene

...ultiple myeloma (a cancer affect blood-forming cells) and acute myelogenous leukemia. Stat3 also plays a role in chronic virus infections, asthma, psoriasis and inflammatory bowel disease all areas that Tweardy and his colleagues hope to pursue in the future. ...

Compromised skin barrier function plays a role in psorasis development

... is the first study ever done on a Chinese population all other studies on psoriasis so far have focused on western populations." All three independent studies will be published by Nature Genetics at the same time. psoriasis is a common chronic, auto-immune and hyper-proliferative skin disease, usua...

Musculoskeletal center wins $2.2 million for drug safety

...called biologics. These are genetically engineered therapies that target the immune system of patients who have rheumatoid arthritis, Crohn's disease, psoriasis and other autoimmune disorders. The award will allow the UAB CERTs to pinpoint which biologics have potential safety concerns. Additionally, resear...

Green tea may delay onset of type 1 diabetes

...in psoriasis, an autoimmune disease affecting the skin and joints, says Dr. Hsu. "Normal skin cells turn over every 30 days or so, but skin cells with psoriasis turn over every two or three days." Dr. Hsu's group previously found that green tea polyphenols, including EGCG, inhibited rapid proliferation in an a...

Psoriasis in Biological Technology

avVaa World Health Care Products Inc. Announces Web Site Design for Neuroskin(R) Psoriasis Relief DRTV Campaign

LUMBY, BC, July 16 /PRNewswire-FirstCall/ - avVaa World Health Care Products Inc. (Pink Sheets: AVVH), a global biotechnology company, manufacturer and distributor of nationally branded therapeutic, natural skin and health care products announced that the Company has hired a web design firm to des...

Latest BioTrends Research Reports to Assess the Impact of the Withdrawal of Raptiva (efalizumab) on the Psoriasis Market

EXTON, Pa., April 10 /PRNewswire/ -- On April 8th, 2009, Genentech and Roche announced the voluntary withdrawal of Raptiva (efalizumab, marketed by Genentech/Roche and Xoma) from the US market. The withdrawal comes after recent post-marketing reports of PML associated with Raptiva treatment. ...

Photos: 'Project Runway's' Tim Gunn Launches Addressing Psoriasis(TM) Campaign to Advocate That Patients Shouldn't Let Psoriasis Impact Personal Style

Campaign Sponsored by Amgen and Wyeth Offers a Chance to Win a Walk on the Runway in New York City Fashion Show NEW YORK, March 4 /PRNewswire-FirstCall/ -- Amgen and Wyeth today announced that they have partnered with Tim Gunn, television host and fashion consultant ("Project Runway," "Ti...

Centocor/Janssen-Cilag's Ustekinumab Will Become the Gold Standard for Psoriasis By 2011

Competitive Advantages in Efficacy Will Drive Prescription Rates, According to a New Report from Decision Resources WALTHAM, Mass., Feb. 13 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, ...

NeoStrata(R) Announces the Launch of PSORENT(TM) Psoriasis Topical Treatment

PSORENT Features a Unique and Innovative Formulation Available Without a Prescription Through Physicians PRINCETON, N.J., Feb. 4 /PRNewswire/ -- NeoStrata today announced the launch of PSORENT, a clinically proven, steroid-free, topical treatment for psoriasis. PSORENT conta...

Specialists Are Turning to Biologics Earlier in the Treatment of Psoriasis and Psoriatic Arthritis

Managed Care Organizations Aggressively Control Access to Biologics, According to a New Report from Decision Resources WALTHAM, Mass., Sept. 10 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds...

BioCis Pharma Starts Phase IIa Trial in Psoriasis

TURKU, Finland, March 12 /PRNewswire/ -- BioCis Pharma Ltd., a privately-held drug development company with its headquarters in Turku, Finland, announced that it has begun a new Phase IIa clinical testing of ProtoCure(TM) emulsion cream, the company's novel topical drug for dermatology. The do...

New Biologic STELARA(TM) Receives Approval in Europe for Treatment of Moderate to Severe Plaque Psoriasis

First and Only Biologic Approved with Infrequent, Every Twelve-Week Maintenance Dosing BEERSE, Belgium, Jan. 22 /PRNewswire/ -- Janssen-Cilag announced today that STELARA(TM) (ustekinumab), the first in a new class of biologics, has been approved by the European Commission for use across Eu...

Dermatologists Report Increased Use of Biologics in the Treatment of Psoriasis

EXTON, Pa., June 5 /PRNewswire/ -- BioTrends Research Group, Inc. released its third annual TreatmentTrends (TM): Psoriasis publication, providing insight into the management of psoriasis. This report is based on responses to an online survey completed by 102 US Dermatologists in April 2008. ...

Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis

MONTVALE, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI ) today announced the signing of an agreement with privately- held Novel Therapeutic Technologies, Inc. to provide Synvista with formulation work for a topical cream formulation of ALT-2074 for the treatm...

Psoriasis in Biological Definition

Immune system

...ticularly autoimmune disorders such as lupus erythematosus , type I diabetes (sometimes called "juvenile onset diabetes"), multiple sclerosis , psoriasis , and rheumatoid arthritis . In these the immune system fails to properly distinguish between self and non-self and attacks a part of the patient's o...

Psoriasis in Biological Dictionary

Photobiology

...ith a Free Trial from HighBeam.com. Credit card req'd. Today's offers at GoDaddy.com. photobiology .net. Sponsored Listings. Led Light Therapy ... psoriasis & Vitiligo treatment Home Systems are available ... Online Shopping at DirectTextBook.com - Save up to 80%, buy or rent. New and used books lik...

Biologics

...sion) ... Biologics are used to treat moderate to severe chronic plaque psoriasis and psoriatic arthritis. ... Follow The Peters Bieling As They Take You ... briefly explains why the biologics provide a unique treatment option for psoriasis and psoriatic arthritis. Cytovance® Biologics Announces the Company is...

Anus

..., ring, anus . ... anus ... Learn about the causes of anal itching like pinworms, diarrhea, psoriasis, anal fissure, hemorrhoids, skin tags, ... psoriasis also can irritate the anus . ... Learn more about anal cancer, its causes, risk factors, signs and symptoms, diagnosis, treatment, and how the sta...